108P - Treatment compliance, tolerance and efficacy in elderly patients with advanced non-small cell lung cancer receiving first line chemotherapy: a compa...
|Date||28 March 2014|
|Session||Lunch and poster display session|
Non-Small-Cell Lung Cancer, Metastatic
|Citation||Journal of Thoracic Oncology (2014) 9 (Supplement 9): S7-S52. 10.1097/JTO.0000000000000131|
G. Mountzios1, M. Bakogeorgos2, E. Mpournakis2, P. Economopoulou1, N. Kentepozidis1, M.A. Dimopoulos2
Elderly patients with advanced non-small cell lung cancer (NSCLC) tend to receive suboptimal treatment mainly due to fears of poor compliance and excessive toxicity.